Obesity Trial, Recruiting NCT06425796 Sponsor: University of Ulster Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06425796
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who are pregnant and aged 18 or older
  • Women with a body mass index (BMI) of 18.5 or above (a standard measure of body weight relative to height)
  • Women who are currently pregnant without complications such as severe bleeding, diabetes during pregnancy, severe morning sickness, or abnormal pregnancies (such as ectopic or molar pregnancies)
  • Women who are at least 12 weeks pregnant
  • Women carrying a single baby, confirmed by their first ultrasound
  • Women currently taking multivitamin supplements may be considered, though they would be asked to stop taking those supplements if they joined the trial

Who may not be able to join:

  • Women whose haemoglobin (a measure of red blood cells in the blood) is below a certain level, indicating low iron (confirm with trial site for exact threshold)
  • Women whose serum ferritin (a measure of iron stored in the body) is below a certain level (confirm with trial site for exact threshold)
  • Women who have blood results suggesting a high risk of having too much iron in the body (confirm with trial site for exact thresholds)
  • Women with a history of blood disorders, kidney disease, liver disease, autoimmune conditions, or conditions that affect how the body absorbs nutrients
  • Women who have had weight-loss (bariatric) surgery in the past
  • Women who take steroid medications, anti-inflammatory drugs, or medications that affect how the stomach and gut work (such as proton-pump inhibitors for acid reflux)
  • Women who are planning to give birth at home
  • Women who are currently taking part in another research study
  • Women carrying more than one baby (such as twins or triplets)
  • Women who do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mary McCann, PhD, University of Ulster

Phone: +4402870123969

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Ulster
Registry
ClinicalTrials.gov
Start date
20 May 2024
Est. completion
19 January 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

* - Adjusted maternal ferritin concentrations in response to iron supplementation (ng/mL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov